Skip to main content

GOLDMAN SACHS GROUP INC

Position in ORGO — Organogenesis Holdings Inc.

CIK 886982 NEW YORK, NY

Position in ORGO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,156,378
+$923,150 QoQ
Shares Held
887,399
+70.5% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#16
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ORGO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. ORGO ranks #38 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ORGO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,156,378 887,399
2026-03-31 $1,233,228 520,350
2025-12-31 $2,166,503 418,244
2025-09-30 $967,586 229,286
2025-06-30 $730,846 199,685
2025-03-31 $1,823,168 422,030
2024-12-31 $2,099,698 656,156
2024-09-30 $779,723 272,631
2024-06-30 $694,259 247,950
2024-03-31 $530,702 186,867
2023-12-31 $834,351 203,998
2023-09-30 $864,809 271,953
2023-06-30 $717,105 215,996
2023-03-31 $1,309,063 614,584
2022-12-31 $2,086,502 775,652
2022-09-30 $3,133,391 967,096
2022-06-30 $5,115,756 1,048,311
2022-03-31 $7,036,963 923,486
2021-12-31 $7,690,849 832,343
2021-09-30 $10,701,829 751,533
2021-06-30 $19,153,270 1,152,423
2021-03-31 $1,733,814 95,160
2020-12-31 $517,190 68,684
2020-09-30 $111,694 29,087
2020-06-30 $209,571 54,576
2020-03-31 $58,320 18,056